ARTICLE | Company News
bioMerieux sales and marketing update
February 19, 2007 8:00 AM UTC
BIM launched its chromID vancomycin resistant enterococci (VRE) and chromID extended-spectrum beta-lactamase ( ESBL) chromogenic culture media outside the U.S. The company also launched its DiversiLab...